ID,Age,Sex,Disease,BM disease burden,Bone marrow cellularity,extramedullary mass,extranodal involvement,B symptoms,Ann Arbor stage,Number of prior therapy lines,Prior hematopoietic stem cell,Prior CAR-T therapy,Bridging therapy,CAR-T therapy following auto-HSCT,Costimulatory molecule,Type of construct(tandem/single target),CAR-T cell infusion date,CRS grade,ICANS grade,Early ICAHT grade,Late ICAHT grade,Infection grade
4,35,Female,ALL,0.0,Normal_active,No,0,No,Stage3,4,Allogeneic,Yes,Yes,Yes,41BB+CD28,Tandem,2024-06-24,1,0,3,3.0,3
